Evommune
United StatesEntry
2024
Hold
1yr
Exit
2025
Who owns Evommune?
Evommune was owned by Oscar & Paul (Beiersdorf Venture Capital) through Oscar & Paul Venture Capital Fund I (2020 vintage) from 2024 to 2025, exited via IPO. Across its history, Evommune has been through 2 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
Oscar & Paul (Beiersdorf Venture Capital)Oscar & Paul Venture Capital Fund I · 2020 · VC
2 ownership periods · full history below
Key facts
Key takeaways
- ·Fully exited in 2025.
- ·Average hold across 2 realized cycles: 3 years.
Ownership history
2 ownership periods · co-invest detected
Exited
Last exited in 2025 to .
Co-invest · 2 holders · 2021 · 2025
Oscar & Paul (Beiersdorf Venture Capital)Exited 2025
2024 · 2025(1yr) · Oscar & Paul Venture Capital Fund I · 2020 · VC
IPO
MOIC
–
More from Oscar & Paul Venture Capital Fund I
Other portfolio companies in the same fund.
United Kingdom
Sweden
FranceMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Track Evommune
Save this record to your watchlist and pick up your research where you left off. No spam.
Get the full record on Evommune.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue